Senior Vice President, Strategic Research

Andrew Branca has ten years' experience in providing strategic business analysis and consulting to pharmaceutical, biotechnology, and drug discovery technology companies. Andrew also leads CHA's strategic business planing efforts. He is a highly sought consultant to major pharmaceutical companies and a frequent speaker at industry events.

Prior to joining Cambridge Healthtech, Andrew was Director of the Breakthrough Technologies service at Decision Resources. In this role, he evaluated the strategic and scientific promise and the market potential of emerging drug discovery technologies. Andrew received his graduate education in Molecular Biology at Harvard University. He also holds a BA from Binghamton University and a JD from the Hofstra University School of Law.

E-mail: Email
Direct: 781-320-4009